ID   1433B_HUMAN             Reviewed;         246 AA.
AC   P31946; A8K9K2; E1P616;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   25-OCT-2017, entry version 202.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein 1054;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=YWHAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11; 30-51; 63-73 AND 130-159, INTERACTION WITH
RP   PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-11; 14-57; 63-70; 106-117; 130-169 AND 215-246,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 3-20.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [10]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [11]
RP   INTERACTION WITH YWHAB.
RX   PubMed=15538381; DOI=10.1038/sj.emboj.7600477;
RA   Schmidlin M., Lu M., Leuenberger S.A., Stoecklin G., Mallaun M.,
RA   Gross B., Gherzi R., Hess D., Hemmings B.A., Moroni C.;
RT   "The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by
RT   protein kinase B.";
RL   EMBO J. 23:4760-4769(2004).
RN   [12]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [13]
RP   INTERACTION WITH ABL1.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   INTERACTION WITH YAP1.
RX   PubMed=17974916; DOI=10.1101/gad.1602907;
RA   Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J.,
RA   Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G.,
RA   Lai Z.C., Guan K.L.;
RT   "Inactivation of YAP oncoprotein by the Hippo pathway is involved in
RT   cell contact inhibition and tissue growth control.";
RL   Genes Dev. 21:2747-2761(2007).
RN   [16]
RP   INTERACTION WITH ROR2, FUNCTION, PHOSPHORYLATION, DIMERIZATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17717073; DOI=10.1210/me.2007-0323;
RA   Liu Y., Ross J.F., Bodine P.V.N., Billiard J.;
RT   "Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-
RT   3(beta) phosphorylation and promotes osteoblast differentiation and
RT   bone formation.";
RL   Mol. Endocrinol. 21:3050-3061(2007).
RN   [17]
RP   INTERACTION WITH SIRT2.
RX   PubMed=18249187; DOI=10.1016/j.bbrc.2008.01.114;
RA   Jin Y.H., Kim Y.J., Kim D.W., Baek K.H., Kang B.Y., Yeo C.Y.,
RA   Lee K.Y.;
RT   "Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the
RT   activity of p53.";
RL   Biochem. Biophys. Res. Commun. 368:690-695(2008).
RN   [18]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [19]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a
RT   phosphorylation-dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH AKAP13.
RX   PubMed=21224381; DOI=10.1074/jbc.M110.185645;
RA   Cariolato L., Cavin S., Diviani D.;
RT   "A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling
RT   complex involved in alpha1-adrenergic receptor-induced p38
RT   activation.";
RL   J. Biol. Chem. 286:7925-7937(2011).
RN   [25]
RP   INTERACTION WITH SOS1.
RX   PubMed=22827337; DOI=10.1042/BJ20120938;
RA   Saha M., Carriere A., Cheerathodi M., Zhang X., Lavoie G., Rush J.,
RA   Roux P.P., Ballif B.A.;
RT   "RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively
RT   regulating MAPK activation.";
RL   Biochem. J. 447:159-166(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, ACETYLATION
RP   [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM SHORT), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL46 (MICROBIAL INFECTION).
RX   PubMed=23938468; DOI=10.1074/mcp.M113.030866;
RA   Lin A.E., Greco T.M., Dohner K., Sodeik B., Cristea I.M.;
RT   "A proteomic perspective of inbuilt viral protein regulation: pUL46
RT   tegument protein is targeted for degradation by ICP0 during herpes
RT   simplex virus type 1 infection.";
RL   Mol. Cell. Proteomics 12:3237-3252(2013).
RN   [29]
RP   INTERACTION WITH MYO1C.
RX   PubMed=24636949; DOI=10.1016/j.jmb.2014.03.004;
RA   Stefan Munnich M.H., Manstein D.J.;
RT   "Crystal structure of human myosin 1c - the motor in GLUT4 exocytosis:
RT   implications for Ca(2+)-regulation and 14-3-3 binding.";
RL   J. Mol. Biol. 426:2070-2081(2014).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [32]
RP   INTERACTION WITH RIPOR2.
RX   PubMed=25588844; DOI=10.1242/jcs.161497;
RA   Gao K., Tang W., Li Y., Zhang P., Wang D., Yu L., Wang C., Wu D.;
RT   "Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at
RT   leading edges polarizes neutrophils.";
RL   J. Cell Sci. 128:992-1000(2015).
RN   [33]
RP   ACETYLATION AT THR-2, AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=25489052; DOI=10.1093/hmg/ddu611;
RA   Myklebust L.M., Van Damme P., Stoeve S.I., Doerfel M.J., Abboud A.,
RA   Kalvik T.V., Grauffel C., Jonckheere V., Wu Y., Swensen J., Kaasa H.,
RA   Liszczak G., Marmorstein R., Reuter N., Lyon G.J., Gevaert K.,
RA   Arnesen T.;
RT   "Biochemical and cellular analysis of Ogden syndrome reveals
RT   downstream Nt-acetylation defects.";
RL   Hum. Mol. Genet. 24:1956-1976(2015).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-239, IDENTIFICATION BY MASS
RP   SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
RN   [36]
RP   VARIANT ILE-99.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2. Negative regulator of
CC       signaling cascades that mediate activation of MAP kinases via
CC       AKAP13. {ECO:0000269|PubMed:17717073, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:21224381}.
CC   -!- SUBUNIT: Homodimer (PubMed:17717073). Interacts with SAMSN1 and
CC       PRKCE (By similarity). Interacts with AKAP13 (PubMed:21224381).
CC       Interacts with SSH1 and TORC2/CRTC2 (PubMed:15454081,
CC       PubMed:15159416). Interacts with ABL1; the interaction results in
CC       cytoplasmic location of ABL1 and inhibition of cABL-mediated
CC       apoptosis (PubMed:15696159). Interacts with ROR2 (dimer); the
CC       interaction results in phosphorylation of YWHAB on tyrosine
CC       residues (PubMed:17717073). Interacts with GAB2 (PubMed:19172738).
CC       Interacts with YAP1 (phosphorylated form) (PubMed:17974916).
CC       Interacts with the phosphorylated (by AKT1) form of SRPK2
CC       (PubMed:19592491). Interacts with PKA-phosphorylated AANAT
CC       (PubMed:11427721). Interacts with MYO1C (PubMed:24636949).
CC       Interacts with SIRT2 (PubMed:18249187). Interacts with the 'Thr-
CC       369' phosphorylated form of DAPK2 (PubMed:26047703). Interacts
CC       with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552). Interacts
CC       with the 'Ser-1134' and 'Ser-1161' phosphorylated form of SOS1
CC       (PubMed:22827337). Interacts (via phosphorylated form) with YWHAB;
CC       this interaction occurs in a protein kinase AKT1-dependent manner
CC       (PubMed:15538381). Interacts with SLITRK1 (PubMed:19640509).
CC       Interacts with SYNPO2 (phosphorylated form); YWHAB competes with
CC       ACTN2 for interaction with SYNPO2 (By similarity). Interacts with
CC       RIPOR2 (via phosphorylated form) isoform 2; this interaction
CC       occurs in a chemokine-dependent manner and does not compete for
CC       binding of RIPOR2 with RHOA nor blocks inhibition of RIPOR2-
CC       mediated RHOA activity (PubMed:25588844).
CC       {ECO:0000250|UniProtKB:Q9CQV8, ECO:0000269|PubMed:11427721,
CC       ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15454081,
CC       ECO:0000269|PubMed:15538381, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:17717073,
CC       ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:18249187,
CC       ECO:0000269|PubMed:19172738, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:19640509, ECO:0000269|PubMed:21224381,
CC       ECO:0000269|PubMed:22827337, ECO:0000269|PubMed:23572552,
CC       ECO:0000269|PubMed:24636949, ECO:0000269|PubMed:25588844,
CC       ECO:0000269|PubMed:26047703}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus
CC       1 protein UL46. {ECO:0000269|PubMed:23938468}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-359815, EBI-359815;
CC       Q76353:- (xeno); NbExp=3; IntAct=EBI-359815, EBI-6248077;
CC       Q9P0K1-3:ADAM22; NbExp=2; IntAct=EBI-359815, EBI-1567267;
CC       P15056:BRAF; NbExp=3; IntAct=EBI-359815, EBI-365980;
CC       P22681:CBL; NbExp=3; IntAct=EBI-359815, EBI-518228;
CC       O00257:CBX4; NbExp=2; IntAct=EBI-359815, EBI-722425;
CC       P30304:CDC25A; NbExp=10; IntAct=EBI-359815, EBI-747671;
CC       P30305:CDC25B; NbExp=5; IntAct=EBI-359815, EBI-1051746;
CC       P30307:CDC25C; NbExp=4; IntAct=EBI-359815, EBI-974439;
CC       O94921:CDK14; NbExp=5; IntAct=EBI-359815, EBI-1043945;
CC       P67828:CSNK1A1 (xeno); NbExp=3; IntAct=EBI-359815, EBI-7540603;
CC       Q9NYF0:DACT1; NbExp=4; IntAct=EBI-359815, EBI-3951744;
CC       Q13627-2:DYRK1A; NbExp=3; IntAct=EBI-359815, EBI-1053621;
CC       Q9UQC2:GAB2; NbExp=4; IntAct=EBI-359815, EBI-975200;
CC       P55040:GEM; NbExp=3; IntAct=EBI-359815, EBI-744104;
CC       P55041:Gem (xeno); NbExp=3; IntAct=EBI-359815, EBI-7082069;
CC       P56524:HDAC4; NbExp=3; IntAct=EBI-359815, EBI-308629;
CC       Q11184:let-756 (xeno); NbExp=2; IntAct=EBI-359815, EBI-3843983;
CC       Q5S007:LRRK2; NbExp=5; IntAct=EBI-359815, EBI-5323863;
CC       Q99759:MAP3K3; NbExp=2; IntAct=EBI-359815, EBI-307281;
CC       Q99683:MAP3K5; NbExp=3; IntAct=EBI-359815, EBI-476263;
CC       Q7KZI7:MARK2; NbExp=3; IntAct=EBI-359815, EBI-516560;
CC       P27448:MARK3; NbExp=4; IntAct=EBI-359815, EBI-707595;
CC       P26045:PTPN3; NbExp=4; IntAct=EBI-359815, EBI-1047946;
CC       P04049:RAF1; NbExp=18; IntAct=EBI-359815, EBI-365996;
CC       Q96TC7:RMDN3; NbExp=5; IntAct=EBI-359815, EBI-1056589;
CC       P61587:RND3; NbExp=2; IntAct=EBI-359815, EBI-1111534;
CC       P61588:Rnd3 (xeno); NbExp=5; IntAct=EBI-359815, EBI-6930266;
CC       P78362:SRPK2; NbExp=2; IntAct=EBI-359815, EBI-593303;
CC       Q8WYL5:SSH1; NbExp=3; IntAct=EBI-359815, EBI-1222387;
CC       Q91YE8:Synpo2 (xeno); NbExp=3; IntAct=EBI-359815, EBI-7623057;
CC       P49815:TSC2; NbExp=4; IntAct=EBI-359815, EBI-396587;
CC       P46937:YAP1; NbExp=6; IntAct=EBI-359815, EBI-1044059;
CC       P62258:YWHAE; NbExp=4; IntAct=EBI-359815, EBI-356498;
CC       P61981:YWHAG; NbExp=2; IntAct=EBI-359815, EBI-359832;
CC       P27348:YWHAQ; NbExp=2; IntAct=EBI-359815, EBI-359854;
CC       P22893:Zfp36 (xeno); NbExp=5; IntAct=EBI-359815, EBI-647803;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P31946-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P31946-2; Sequence=VSP_018632;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378};
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in
CC       being phosphorylated. Phosphorylated on Ser-60 by protein kinase C
CC       delta type catalytic subunit in a sphingosine-dependent fashion.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57346; CAA40621.1; -; mRNA.
DR   EMBL; AK292717; BAF85406.1; -; mRNA.
DR   EMBL; AL008725; CAA15497.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75893.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75894.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75896.1; -; Genomic_DNA.
DR   EMBL; BC001359; AAH01359.1; -; mRNA.
DR   CCDS; CCDS13339.1; -. [P31946-1]
DR   PIR; S34755; S34755.
DR   RefSeq; NP_003395.1; NM_003404.4. [P31946-1]
DR   RefSeq; NP_647539.1; NM_139323.3. [P31946-1]
DR   RefSeq; XP_016883528.1; XM_017028039.1. [P31946-1]
DR   UniGene; Hs.643544; -.
DR   PDB; 2BQ0; X-ray; 2.50 A; A/B=2-239.
DR   PDB; 2C23; X-ray; 2.65 A; A=2-239.
DR   PDB; 4DNK; X-ray; 2.20 A; A/B=1-246.
DR   PDB; 5N10; X-ray; 1.60 A; A/B=1-246.
DR   PDBsum; 2BQ0; -.
DR   PDBsum; 2C23; -.
DR   PDBsum; 4DNK; -.
DR   PDBsum; 5N10; -.
DR   ProteinModelPortal; P31946; -.
DR   SMR; P31946; -.
DR   BioGrid; 113361; 353.
DR   CORUM; P31946; -.
DR   DIP; DIP-743N; -.
DR   ELM; P31946; -.
DR   IntAct; P31946; 270.
DR   MINT; MINT-99570; -.
DR   STRING; 9606.ENSP00000300161; -.
DR   ChEMBL; CHEMBL3710403; -.
DR   iPTMnet; P31946; -.
DR   PhosphoSitePlus; P31946; -.
DR   SwissPalm; P31946; -.
DR   DMDM; 1345590; -.
DR   OGP; P31946; -.
DR   REPRODUCTION-2DPAGE; IPI00216318; -.
DR   EPD; P31946; -.
DR   PaxDb; P31946; -.
DR   PeptideAtlas; P31946; -.
DR   PRIDE; P31946; -.
DR   TopDownProteomics; P31946-1; -. [P31946-1]
DR   TopDownProteomics; P31946-2; -. [P31946-2]
DR   DNASU; 7529; -.
DR   Ensembl; ENST00000353703; ENSP00000300161; ENSG00000166913. [P31946-1]
DR   Ensembl; ENST00000372839; ENSP00000361930; ENSG00000166913. [P31946-1]
DR   GeneID; 7529; -.
DR   KEGG; hsa:7529; -.
DR   CTD; 7529; -.
DR   DisGeNET; 7529; -.
DR   EuPathDB; HostDB:ENSG00000166913.12; -.
DR   GeneCards; YWHAB; -.
DR   HGNC; HGNC:12849; YWHAB.
DR   HPA; CAB003759; -.
DR   HPA; HPA007925; -.
DR   HPA; HPA011212; -.
DR   MIM; 601289; gene.
DR   neXtProt; NX_P31946; -.
DR   OpenTargets; ENSG00000166913; -.
DR   PharmGKB; PA37438; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00760000119116; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P31946; -.
DR   KO; K16197; -.
DR   OMA; KKQQMGR; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; P31946; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-165159; mTOR signalling.
DR   Reactome; R-HSA-166208; mTORC1-mediated signalling.
DR   Reactome; R-HSA-170968; Frs2-mediated activation.
DR   Reactome; R-HSA-170984; ARMS-mediated activation.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-392517; Rap1 signalling.
DR   Reactome; R-HSA-450385; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA.
DR   Reactome; R-HSA-450513; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   SignaLink; P31946; -.
DR   SIGNOR; P31946; -.
DR   ChiTaRS; YWHAB; human.
DR   EvolutionaryTrace; P31946; -.
DR   GeneWiki; YWHAB; -.
DR   GenomeRNAi; 7529; -.
DR   PRO; PR:P31946; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000166913; -.
DR   CleanEx; HS_YWHAB; -.
DR   ExpressionAtlas; P31946; baseline and differential.
DR   Genevisible; P31946; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine residue binding; IPI:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:BHF-UCL.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Isopeptide bond; Nitration; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367900.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25489052,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000003.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25489052,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       5      5       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      51     51       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      84     84       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     106    106       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     117    117       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68251}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     51     51       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018632.
FT   VARIANT      99     99       V -> I (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064762.
FT   HELIX         5     17       {ECO:0000244|PDB:4DNK}.
FT   HELIX        21     33       {ECO:0000244|PDB:4DNK}.
FT   HELIX        40     69       {ECO:0000244|PDB:4DNK}.
FT   HELIX        75    105       {ECO:0000244|PDB:4DNK}.
FT   HELIX       107    110       {ECO:0000244|PDB:4DNK}.
FT   HELIX       114    133       {ECO:0000244|PDB:4DNK}.
FT   HELIX       139    161       {ECO:0000244|PDB:4DNK}.
FT   HELIX       167    182       {ECO:0000244|PDB:4DNK}.
FT   HELIX       187    202       {ECO:0000244|PDB:4DNK}.
FT   HELIX       203    207       {ECO:0000244|PDB:4DNK}.
FT   TURN        210    212       {ECO:0000244|PDB:4DNK}.
FT   HELIX       213    232       {ECO:0000244|PDB:4DNK}.
SQ   SEQUENCE   246 AA;  28082 MW;  6BE1A9BF97468017 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   1433E_HUMAN             Reviewed;         255 AA.
AC   P62258; B3KY71; D3DTH5; P29360; P42655; Q4VJB6; Q53XZ5; Q63631;
AC   Q7M4R4;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-NOV-2017, entry version 161.
DE   RecName: Full=14-3-3 protein epsilon;
DE            Short=14-3-3E;
GN   Name=YWHAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7644510; DOI=10.1073/pnas.92.17.7892;
RA   Conklin D.S., Galaktionov K., Beach D.;
RT   "14-3-3 proteins associate with cdc25 phosphatases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7892-7896(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8858348; DOI=10.1101/gr.6.8.735;
RA   Chong S.S., Tanigami A., Roschke A.V., Ledbetter D.H.;
RT   "14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on
RT   chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome
RT   region.";
RL   Genome Res. 6:735-741(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8684458; DOI=10.1038/382308a0;
RA   Jin D.-Y., Lyu M.S., Kozak C.A., Jeang K.-T.;
RT   "Function of 14-3-3 proteins.";
RL   Nature 382:308-308(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=20417184; DOI=10.1016/j.bbrc.2010.04.104;
RA   Han D., Ye G., Liu T., Chen C., Yang X., Wan B., Pan Y., Yu L.;
RT   "Functional identification of a novel 14-3-3 epsilon splicing variant
RT   suggests dimerization is not necessary for 14-3-3 epsilon to inhibit
RT   UV-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 396:401-406(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Luk S.C.W., Lee C.Y., Waye M.M.Y.;
RT   "Sequence determination of human epsilon 14-3-3 protein.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tanigami A., Chong S.S., Ledbetter D.H.;
RT   "14-3-3 epsilon genomic sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND SV).
RC   TISSUE=Caudate nucleus, Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 1-19.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-56; 62-73; 95-118; 131-193 AND 197-255,
RP   INTERACTION WITH PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [13]
RP   PROTEIN SEQUENCE OF 1-19; 30-50 AND 131-170, ACETYLATION AT MET-1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [14]
RP   PROTEIN SEQUENCE OF 50-60, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/MCB.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [15]
RP   PROTEIN SEQUENCE OF 103-108; 120-123; 131-141 AND 143-153.
RC   TISSUE=Histiocytic lymphoma;
RX   PubMed=2026444;
RA   Demeter J., Medzihradszky D., Kha H., Goetzl E.J., Turck C.W.;
RT   "Isolation and partial characterization of the structures of
RT   fibroblast activating factor-related proteins from U937 cells.";
RL   Immunology 72:350-354(1991).
RN   [16]
RP   PROTEIN SEQUENCE OF 131-141 AND 154-190, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [17]
RP   INTERACTION WITH HCV CORE PROTEIN (MICROBIAL INFECTION).
RX   PubMed=10644344; DOI=10.1128/JVI.74.4.1736-1741.2000;
RA   Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.;
RT   "Hepatitis C virus core protein interacts with 14-3-3 protein and
RT   activates the kinase Raf-1.";
RL   J. Virol. 74:1736-1741(2000).
RN   [18]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [19]
RP   INTERACTION WITH CDKN1B, AND SUBCELLULAR LOCATION.
RX   PubMed=12042314; DOI=10.1074/jbc.M203668200;
RA   Fujita N., Sato S., Katayama K., Tsuruo T.;
RT   "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3
RT   and cytoplasmic localization.";
RL   J. Biol. Chem. 277:28706-28713(2002).
RN   [20]
RP   FUNCTION, INTERACTION WITH HSF1, AND SUBCELLULAR LOCATION.
RX   PubMed=12917326; DOI=10.1128/MCB.23.17.6013-6026.2003;
RA   Wang X., Grammatikakis N., Siganou A., Calderwood S.K.;
RT   "Regulation of molecular chaperone gene transcription involves the
RT   serine phosphorylation, 14-3-3 epsilon binding, and cytoplasmic
RT   sequestration of heat shock factor 1.";
RL   Mol. Cell. Biol. 23:6013-6026(2003).
RN   [21]
RP   INTERACTION WITH GRB10.
RX   PubMed=15722337; DOI=10.1074/jbc.M501477200;
RA   Urschel S., Bassermann F., Bai R.Y., Munch S., Peschel C., Duyster J.;
RT   "Phosphorylation of grb10 regulates its interaction with 14-3-3.";
RL   J. Biol. Chem. 280:16987-16993(2005).
RN   [22]
RP   INTERACTION WITH ABL1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [23]
RP   INTERACTION WITH YWHAZ.
RX   PubMed=16376338; DOI=10.1016/j.febslet.2005.12.024;
RA   Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.;
RT   "Protein kinase A phosphorylates and regulates dimerization of 14-3-3
RT   epsilon.";
RL   FEBS Lett. 580:305-310(2006).
RN   [24]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [25]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a
RT   phosphorylation-dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [29]
RP   INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-69; LYS-118 AND
RP   LYS-123, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [37]
RP   INTERACTION WITH DENND1A.
RX   PubMed=26055712; DOI=10.1074/jbc.M115.636712;
RA   Kulasekaran G., Nossova N., Marat A.L., Lund I., Cremer C.,
RA   Ioannou M.S., McPherson P.S.;
RT   "Phosphorylation-dependent regulation of Connecdenn/DENND1 guanine
RT   nucleotide exchange factors.";
RL   J. Biol. Chem. 290:17999-18008(2015).
RN   [38]
RP   INTERACTION WITH RIPOR2.
RX   PubMed=25588844; DOI=10.1242/jcs.161497;
RA   Gao K., Tang W., Li Y., Zhang P., Wang D., Yu L., Wang C., Wu D.;
RT   "Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at
RT   leading edges polarizes neutrophils.";
RL   J. Cell Sci. 128:992-1000(2015).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-233, IDENTIFICATION BY
RP   MASS SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner (By
CC       similarity). Positively regulates phosphorylated protein HSF1
CC       nuclear export to the cytoplasm (PubMed:12917326).
CC       {ECO:0000250|UniProtKB:P62261, ECO:0000269|PubMed:12917326}.
CC   -!- SUBUNIT: Homodimer (PubMed:17085597). Heterodimerizes with YWHAZ
CC       (PubMed:16376338). Interacts with PKA-phosphorylated AANAT
CC       (PubMed:11427721). Interacts with ABL1 (phosphorylated form); the
CC       interaction retains it in the cytoplasm (PubMed:15696159).
CC       Interacts with ARHGEF28 (By similarity). Interacts with BEX3 (By
CC       similarity). Weakly interacts with CDKN1B (PubMed:12042314).
CC       Interacts with the 'Thr-369' phosphorylated form of DAPK2
CC       (PubMed:26047703). Interacts with DENND1A (PubMed:26055712).
CC       Interacts with GAB2 (PubMed:19172738). Interacts with
CC       phosphorylated GRB10 (PubMed:15722337). Interacts with KSR1
CC       (PubMed:10409742). Interacts with NDEL1 (By similarity). Interacts
CC       with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552). Interacts
CC       with the phosphorylated (by AKT1) form of SRPK2 (PubMed:19592491).
CC       Interacts with TIAM2. Interacts with the 'Ser-1134' and 'Ser-1161'
CC       phosphorylated form of SOS1 (By similarity). Interacts with ZFP36
CC       (via phosphorylated form) (By similarity). Interacts with SLITRK1
CC       (PubMed:19640509). Interacts with HSF1 (via phosphorylated form);
CC       this interaction promotes HSF1 sequestration in the cytoplasm in a
CC       ERK-dependent manner (PubMed:12917326). Interacts with RIPOR2
CC       isoform 2 (PubMed:25588844). {ECO:0000250|UniProtKB:P62259,
CC       ECO:0000250|UniProtKB:P62260, ECO:0000269|PubMed:10409742,
CC       ECO:0000269|PubMed:11427721, ECO:0000269|PubMed:12042314,
CC       ECO:0000269|PubMed:12917326, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:15722337, ECO:0000269|PubMed:16376338,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:19172738,
CC       ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:19640509,
CC       ECO:0000269|PubMed:23572552, ECO:0000269|PubMed:25588844,
CC       ECO:0000269|PubMed:26047703, ECO:0000269|PubMed:26055712}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV core protein.
CC       {ECO:0000269|PubMed:10644344}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-356498, EBI-356498;
CC       O92972:- (xeno); NbExp=5; IntAct=EBI-356498, EBI-9213553;
CC       Q96AP0:ACD; NbExp=2; IntAct=EBI-356498, EBI-717666;
CC       O14727:APAF1; NbExp=2; IntAct=EBI-356498, EBI-446492;
CC       P10398:ARAF; NbExp=3; IntAct=EBI-356498, EBI-365961;
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-356498, EBI-4392727;
CC       Q9Y3M2:CBY1; NbExp=3; IntAct=EBI-356498, EBI-947308;
CC       Q86Z20:CCDC125; NbExp=4; IntAct=EBI-356498, EBI-11977221;
CC       O94921:CDK14; NbExp=3; IntAct=EBI-356498, EBI-1043945;
CC       Q9UKT5:FBXO4; NbExp=5; IntAct=EBI-356498, EBI-960409;
CC       P56524:HDAC4; NbExp=4; IntAct=EBI-356498, EBI-308629;
CC       Q14678-2:KANK1; NbExp=3; IntAct=EBI-356498, EBI-6173812;
CC       Q5S007:LRRK2; NbExp=6; IntAct=EBI-356498, EBI-5323863;
CC       Q99759:MAP3K3; NbExp=3; IntAct=EBI-356498, EBI-307281;
CC       O15151:MDM4; NbExp=3; IntAct=EBI-356498, EBI-398437;
CC       P58340:MLF1; NbExp=3; IntAct=EBI-356498, EBI-721328;
CC       O35244:Prdx6 (xeno); NbExp=2; IntAct=EBI-356498, EBI-915490;
CC       P04049:RAF1; NbExp=3; IntAct=EBI-356498, EBI-365996;
CC       P61588:Rnd3 (xeno); NbExp=2; IntAct=EBI-356498, EBI-6930266;
CC       Q99469:STAC; NbExp=2; IntAct=EBI-356498, EBI-2652799;
CC       Q9GZV5:WWTR1; NbExp=3; IntAct=EBI-356498, EBI-747743;
CC       P46937:YAP1; NbExp=5; IntAct=EBI-356498, EBI-1044059;
CC       P31946:YWHAB; NbExp=4; IntAct=EBI-356498, EBI-359815;
CC       P61981:YWHAG; NbExp=5; IntAct=EBI-356498, EBI-359832;
CC       P27348:YWHAQ; NbExp=4; IntAct=EBI-356498, EBI-359854;
CC       P63104:YWHAZ; NbExp=6; IntAct=EBI-356498, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12917326}.
CC       Cytoplasm {ECO:0000269|PubMed:12917326}. Melanosome
CC       {ECO:0000269|PubMed:12042314, ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. {ECO:0000269|PubMed:12042314,
CC       ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P62258-1; Sequence=Displayed;
CC       Name=SV;
CC         IsoId=P62258-2; Sequence=VSP_040621;
CC         Note=Unable to dimerize with YWHAZ.;
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20972; AAC50175.1; -; mRNA.
DR   EMBL; U54778; AAC50710.1; -; mRNA.
DR   EMBL; U43399; AAC50625.1; -; mRNA.
DR   EMBL; U43430; AAD00026.1; -; mRNA.
DR   EMBL; U28936; AAA75301.1; -; mRNA.
DR   EMBL; AB017103; BAA32538.1; -; Genomic_DNA.
DR   EMBL; AY883089; AAX68683.1; -; mRNA.
DR   EMBL; AK128785; BAG54733.1; -; mRNA.
DR   EMBL; AK295260; BAG58249.1; -; mRNA.
DR   EMBL; AK316185; BAH14556.1; -; mRNA.
DR   EMBL; BT007161; AAP35825.1; -; mRNA.
DR   EMBL; CH471108; EAW90628.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90629.1; -; Genomic_DNA.
DR   EMBL; BC000179; AAH00179.1; -; mRNA.
DR   EMBL; BC001440; AAH01440.1; -; mRNA.
DR   CCDS; CCDS11001.1; -. [P62258-1]
DR   PIR; A61235; A61235.
DR   PIR; I38947; I38947.
DR   RefSeq; NP_006752.1; NM_006761.4. [P62258-1]
DR   UniGene; Hs.513851; -.
DR   PDB; 2BR9; X-ray; 1.75 A; A=1-233.
DR   PDB; 3UAL; X-ray; 1.80 A; A=1-232.
DR   PDB; 3UBW; X-ray; 1.90 A; A=1-234.
DR   PDBsum; 2BR9; -.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   ProteinModelPortal; P62258; -.
DR   SMR; P62258; -.
DR   BioGrid; 113363; 419.
DR   CORUM; P62258; -.
DR   DIP; DIP-36676N; -.
DR   ELM; P62258; -.
DR   IntAct; P62258; 179.
DR   MINT; MINT-4998623; -.
DR   STRING; 9606.ENSP00000264335; -.
DR   ChEMBL; CHEMBL3329082; -.
DR   DrugBank; DB01780; Fusicoccin.
DR   iPTMnet; P62258; -.
DR   PhosphoSitePlus; P62258; -.
DR   SwissPalm; P62258; -.
DR   BioMuta; YWHAE; -.
DR   DMDM; 51702210; -.
DR   OGP; P42655; -.
DR   UCD-2DPAGE; P62258; -.
DR   EPD; P62258; -.
DR   PaxDb; P62258; -.
DR   PeptideAtlas; P62258; -.
DR   PRIDE; P62258; -.
DR   TopDownProteomics; P62258-1; -. [P62258-1]
DR   DNASU; 7531; -.
DR   Ensembl; ENST00000264335; ENSP00000264335; ENSG00000108953. [P62258-1]
DR   Ensembl; ENST00000571732; ENSP00000461762; ENSG00000108953. [P62258-2]
DR   Ensembl; ENST00000616643; ENSP00000481059; ENSG00000274474. [P62258-2]
DR   Ensembl; ENST00000627231; ENSP00000487356; ENSG00000274474. [P62258-1]
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsk.4; human. [P62258-1]
DR   CTD; 7531; -.
DR   DisGeNET; 7531; -.
DR   EuPathDB; HostDB:ENSG00000108953.16; -.
DR   GeneCards; YWHAE; -.
DR   H-InvDB; HIX0013751; -.
DR   H-InvDB; HIX0030006; -.
DR   HGNC; HGNC:12851; YWHAE.
DR   HPA; CAB016200; -.
DR   HPA; CAB021109; -.
DR   HPA; CAB047350; -.
DR   HPA; HPA008445; -.
DR   MalaCards; YWHAE; -.
DR   MIM; 605066; gene.
DR   neXtProt; NX_P62258; -.
DR   OpenTargets; ENSG00000108953; -.
DR   Orphanet; 217385; 17p13.3 microduplication syndrome.
DR   Orphanet; 261257; Distal 17p13.3 microdeletion syndrome.
DR   Orphanet; 531; Miller-Dieker syndrome.
DR   PharmGKB; PA37440; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00760000119116; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P62258; -.
DR   KO; K06630; -.
DR   OMA; IPCATTG; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; P62258; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-205025; NADE modulates death signalling.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   SignaLink; P62258; -.
DR   SIGNOR; P62258; -.
DR   ChiTaRS; YWHAE; human.
DR   EvolutionaryTrace; P62258; -.
DR   GeneWiki; YWHAE; -.
DR   GenomeRNAi; 7531; -.
DR   PMAP-CutDB; P62258; -.
DR   PRO; PR:P62258; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108953; -.
DR   CleanEx; HS_YWHAE; -.
DR   ExpressionAtlas; P62258; baseline and differential.
DR   Genevisible; P62258; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005871; C:kinesin complex; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:SynGO-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0023026; F:MHC class II protein complex binding; IDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine residue binding; IPI:BHF-UCL.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0017112; F:Rab guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:1905913; P:negative regulation of calcium ion export from cell; IDA:SynGO-UCL.
DR   GO; GO:1901020; P:negative regulation of calcium ion transmembrane transporter activity; IDA:SynGO-UCL.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome.
DR   GO; GO:1902309; P:negative regulation of peptidyl-serine dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IDA:UniProtKB.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:SynGO-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IC:BHF-UCL.
DR   GO; GO:0003064; P:regulation of heart rate by hormone; NAS:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0021762; P:substantia nigra development; IEP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1    255       14-3-3 protein epsilon.
FT                                /FTId=PRO_0000058618.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        130    130       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.13}.
FT   MOD_RES      50     50       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P62260}.
FT   MOD_RES      69     69       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     118    118       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     123    123       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     131    131       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P62260}.
FT   MOD_RES     137    137       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P62260}.
FT   MOD_RES     210    210       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     232    232       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     50     50       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     22       Missing (in isoform SV).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:20417184}.
FT                                /FTId=VSP_040621.
FT   CONFLICT    106    107       KH -> NY (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       E -> F (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    148    148       S -> T (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX         4     17       {ECO:0000244|PDB:2BR9}.
FT   HELIX        20     31       {ECO:0000244|PDB:2BR9}.
FT   HELIX        39     73       {ECO:0000244|PDB:2BR9}.
FT   HELIX        76    106       {ECO:0000244|PDB:2BR9}.
FT   HELIX       108    111       {ECO:0000244|PDB:2BR9}.
FT   HELIX       115    135       {ECO:0000244|PDB:2BR9}.
FT   HELIX       138    162       {ECO:0000244|PDB:2BR9}.
FT   HELIX       168    183       {ECO:0000244|PDB:2BR9}.
FT   HELIX       188    204       {ECO:0000244|PDB:2BR9}.
FT   HELIX       205    208       {ECO:0000244|PDB:2BR9}.
FT   TURN        211    213       {ECO:0000244|PDB:2BR9}.
FT   HELIX       214    231       {ECO:0000244|PDB:2BR9}.
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   1433F_HUMAN             Reviewed;         246 AA.
AC   Q04917;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   25-OCT-2017, entry version 195.
DE   RecName: Full=14-3-3 protein eta;
DE   AltName: Full=Protein AS1;
GN   Name=YWHAH; Synonyms=YWHA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8218406; DOI=10.1016/0167-4781(93)90053-G;
RA   Swanson K.D., Dhar M.S., Joshi J.G.;
RT   "The human and bovine 14-3-3 eta protein mRNAs are highly conserved in
RT   both their translated and untranslated regions.";
RL   Biochim. Biophys. Acta 1216:145-148(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=1578511; DOI=10.1002/jnr.490310403;
RA   Ichimura-Ohshima Y., Morii K., Ichimura T., Araki K., Takahashi Y.,
RA   Isobe T., Minoshima S., Fukuyama R., Shimizu N., Kuwano R.;
RT   "cDNA cloning and chromosome assignment of the gene for human brain
RT   14-3-3 protein eta chain.";
RL   J. Neurosci. Res. 31:600-605(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Leffers H., Tommerup N., Celis J.E.;
RL   Submitted (MAR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8561965; DOI=10.1007/BF02740697;
RA   Muratake T., Hayashi S., Ichimura Y., Morii K., Kuwano R.,
RA   Ichikawa T., Kumanishi T., Isobe T., Watanabe M., Kondo H.;
RT   "The effect on methamphetamine on the mRNA level for 14.3.3 eta chain
RT   in the human cultured cells.";
RL   Mol. Neurobiol. 11:223-230(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8812417; DOI=10.1006/geno.1996.0426;
RA   Muratake T., Hayashi S., Ichikawa T., Kumanishi T., Ichimura Y.,
RA   Kuwano R., Isobe T., Wang Y., Minoshima S., Shimizu N., Takahashi Y.;
RT   "Structural organization and chromosomal assignment of the human 14-3-
RT   3 eta chain gene (YWHAH).";
RL   Genomics 36:63-69(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-225.
RC   TISSUE=Keratinocyte;
RX   PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-10.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-10; 29-50; 62-69; 126-132; 144-155; 163-172 AND
RP   218-227, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT GLY-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V.;
RL   Submitted (AUG-2005) to UniProtKB.
RN   [12]
RP   PROTEIN SEQUENCE OF 1-10; 13-50; 62-78; 111-120 AND 133-162,
RP   INTERACTION WITH PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [13]
RP   INTERACTION WITH AR; ESR1; ESR2; MC2R; NRIP1; NR3C1; PPARBP AND THRA.
RX   PubMed=11266503; DOI=10.1210/mend.15.4.0624;
RA   Zilliacus J., Holter E., Wakui H., Tazawa H., Treuter E.,
RA   Gustafsson J.-A.;
RT   "Regulation of glucocorticoid receptor activity by 14-3-3-dependent
RT   intracellular relocalization of the corepressor RIP140.";
RL   Mol. Endocrinol. 15:501-511(2001).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH PDPK1.
RX   PubMed=12177059; DOI=10.1074/jbc.M205141200;
RA   Sato S., Fujita N., Tsuruo T.;
RT   "Regulation of kinase activity of 3-phosphoinositide-dependent protein
RT   kinase-1 by binding to 14-3-3.";
RL   J. Biol. Chem. 277:39360-39367(2002).
RN   [15]
RP   INTERACTION WITH CDKN1B.
RX   PubMed=14504289; DOI=10.1074/jbc.M306614200;
RA   Fujita N., Sato S., Tsuruo T.;
RT   "Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein
RT   S6 kinases promotes its binding to 14-3-3 and cytoplasmic
RT   localization.";
RL   J. Biol. Chem. 278:49254-49260(2003).
RN   [16]
RP   INTERACTION WITH ABL1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [17]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [18]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a
RT   phosphorylation-dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS), IDENTIFICATION BY MASS
RP   SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC       Negatively regulates the kinase activity of PDPK1.
CC       {ECO:0000269|PubMed:12177059}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with many nuclear
CC       hormone receptors and cofactors including AR, ESR1, ESR2, MC2R,
CC       NR3C1, NRIP1, PPARBP and THRA. Interacts with ABL1 (phosphorylated
CC       form); the interaction retains it in the cytoplasm. Interacts with
CC       ARHGEF28 and CDK16 (By similarity). Weakly interacts with CDKN1B.
CC       Interacts with GAB2. Interacts with KCNK18 in a phosphorylation-
CC       dependent manner. Interacts with SAMSN1 (By similarity). Interacts
CC       with the 'Ser-241' phosphorylated form of PDPK1. Interacts with
CC       the 'Thr-369' phosphorylated form of DAPK2 (PubMed:26047703).
CC       Interacts with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552).
CC       Interacts with SLITRK1 (PubMed:19640509). {ECO:0000250,
CC       ECO:0000269|PubMed:11266503, ECO:0000269|PubMed:12177059,
CC       ECO:0000269|PubMed:14504289, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:19172738,
CC       ECO:0000269|PubMed:19640509, ECO:0000269|PubMed:23572552,
CC       ECO:0000269|PubMed:26047703}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-306940, EBI-306940;
CC       Q96B36:AKT1S1; NbExp=3; IntAct=EBI-306940, EBI-720593;
CC       Q8N5S9:CAMKK1; NbExp=5; IntAct=EBI-306940, EBI-6424030;
CC       P30305:CDC25B; NbExp=4; IntAct=EBI-306940, EBI-1051746;
CC       O94921:CDK14; NbExp=3; IntAct=EBI-306940, EBI-1043945;
CC       P67828:CSNK1A1 (xeno); NbExp=8; IntAct=EBI-306940, EBI-7540603;
CC       O60565:GREM1; NbExp=5; IntAct=EBI-306940, EBI-944395;
CC       P56524:HDAC4; NbExp=4; IntAct=EBI-306940, EBI-308629;
CC       Q14678-2:KANK1; NbExp=3; IntAct=EBI-306940, EBI-6173812;
CC       Q5S007:LRRK2; NbExp=3; IntAct=EBI-306940, EBI-5323863;
CC       Q7KZI7:MARK2; NbExp=8; IntAct=EBI-306940, EBI-516560;
CC       P27448:MARK3; NbExp=4; IntAct=EBI-306940, EBI-707595;
CC       Q96L34:MARK4; NbExp=6; IntAct=EBI-306940, EBI-302319;
CC       Q8TEW0:PARD3; NbExp=6; IntAct=EBI-306940, EBI-81968;
CC       Q9NPB6:PARD6A; NbExp=2; IntAct=EBI-306940, EBI-81876;
CC       Q9BYG5:PARD6B; NbExp=3; IntAct=EBI-306940, EBI-295391;
CC       Q9BYG4:PARD6G; NbExp=2; IntAct=EBI-306940, EBI-295417;
CC       P41743:PRKCI; NbExp=3; IntAct=EBI-306940, EBI-286199;
CC       P04049:RAF1; NbExp=6; IntAct=EBI-306940, EBI-365996;
CC       P61588:Rnd3 (xeno); NbExp=2; IntAct=EBI-306940, EBI-6930266;
CC       P37840-1:SNCA; NbExp=9; IntAct=EBI-306940, EBI-9684465;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in the brain and present in
CC       other tissues albeit at lower levels.
CC   -!- PTM: Phosphorylated on Ser-59 by protein kinase C delta type
CC       catalytic subunit in a sphingosine-dependent fashion.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L20422; AAA35483.1; -; mRNA.
DR   EMBL; X80536; CAA56676.1; -; Genomic_DNA.
DR   EMBL; X78138; CAA55017.1; -; mRNA.
DR   EMBL; X57345; CAA40620.1; -; mRNA.
DR   EMBL; D78577; BAA11418.1; -; Genomic_DNA.
DR   EMBL; S80794; AAB36036.1; -; mRNA.
DR   EMBL; CR456612; CAG30498.1; -; mRNA.
DR   EMBL; Z82248; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003047; AAH03047.1; -; mRNA.
DR   CCDS; CCDS13901.1; -.
DR   PIR; S34756; S34756.
DR   PIR; S38509; S38509.
DR   PIR; S38532; S38532.
DR   RefSeq; NP_003396.1; NM_003405.3.
DR   UniGene; Hs.226755; -.
DR   PDB; 2C63; X-ray; 2.15 A; A/B/C/D=2-246.
DR   PDB; 2C74; X-ray; 2.70 A; A/B=2-246.
DR   PDBsum; 2C63; -.
DR   PDBsum; 2C74; -.
DR   ProteinModelPortal; Q04917; -.
DR   SMR; Q04917; -.
DR   BioGrid; 113365; 217.
DR   CORUM; Q04917; -.
DR   DIP; DIP-27566N; -.
DR   ELM; Q04917; -.
DR   IntAct; Q04917; 215.
DR   MINT; MINT-124456; -.
DR   STRING; 9606.ENSP00000248975; -.
DR   ChEMBL; CHEMBL3708585; -.
DR   iPTMnet; Q04917; -.
DR   PhosphoSitePlus; Q04917; -.
DR   SwissPalm; Q04917; -.
DR   BioMuta; YWHAH; -.
DR   DMDM; 1345593; -.
DR   EPD; Q04917; -.
DR   MaxQB; Q04917; -.
DR   PaxDb; Q04917; -.
DR   PeptideAtlas; Q04917; -.
DR   PRIDE; Q04917; -.
DR   TopDownProteomics; Q04917; -.
DR   DNASU; 7533; -.
DR   Ensembl; ENST00000248975; ENSP00000248975; ENSG00000128245.
DR   GeneID; 7533; -.
DR   KEGG; hsa:7533; -.
DR   UCSC; uc003alz.4; human.
DR   CTD; 7533; -.
DR   DisGeNET; 7533; -.
DR   EuPathDB; HostDB:ENSG00000128245.14; -.
DR   GeneCards; YWHAH; -.
DR   HGNC; HGNC:12853; YWHAH.
DR   HPA; CAB025918; -.
DR   MIM; 113508; gene.
DR   neXtProt; NX_Q04917; -.
DR   OpenTargets; ENSG00000128245; -.
DR   PharmGKB; PA37442; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00760000119116; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; Q04917; -.
DR   KO; K16198; -.
DR   OMA; CERYEDM; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; Q04917; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   SignaLink; Q04917; -.
DR   SIGNOR; Q04917; -.
DR   ChiTaRS; YWHAH; human.
DR   EvolutionaryTrace; Q04917; -.
DR   GeneWiki; YWHAH; -.
DR   GenomeRNAi; 7533; -.
DR   PRO; PR:Q04917; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000128245; -.
DR   CleanEx; HS_YWHAH; -.
DR   ExpressionAtlas; Q04917; baseline and differential.
DR   Genevisible; Q04917; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IC:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0003779; F:actin binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0035259; F:glucocorticoid receptor binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; ISS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0017080; F:sodium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0006713; P:glucocorticoid catabolic process; IDA:UniProtKB.
DR   GO; GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006886; P:intracellular protein transport; ISS:UniProtKB.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IDA:BHF-UCL.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0050774; P:negative regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045664; P:regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IDA:BHF-UCL.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   GO; GO:0021762; P:substantia nigra development; IEP:UniProtKB.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Isopeptide bond; Nitration; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.11}.
FT   CHAIN         2    246       14-3-3 protein eta.
FT                                /FTId=PRO_0000058623.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        132    132       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       2      2       N-acetylglycine. {ECO:0000269|Ref.11}.
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      50     50       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      59     59       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68510}.
FT   MOD_RES      69     69       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      85     85       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     120    120       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   CROSSLNK     50     50       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   CONFLICT    144    144       N -> T (in Ref. 9; CAA40620).
FT                                {ECO:0000305}.
FT   CONFLICT    157    157       A -> G (in Ref. 1; AAA35483).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       Q -> L (in Ref. 1; AAA35483).
FT                                {ECO:0000305}.
FT   HELIX         4     16       {ECO:0000244|PDB:2C63}.
FT   HELIX        20     31       {ECO:0000244|PDB:2C63}.
FT   HELIX        39     73       {ECO:0000244|PDB:2C63}.
FT   HELIX        76    106       {ECO:0000244|PDB:2C63}.
FT   TURN        107    111       {ECO:0000244|PDB:2C63}.
FT   HELIX       117    137       {ECO:0000244|PDB:2C63}.
FT   HELIX       140    164       {ECO:0000244|PDB:2C63}.
FT   HELIX       170    185       {ECO:0000244|PDB:2C63}.
FT   HELIX       190    206       {ECO:0000244|PDB:2C63}.
FT   HELIX       207    210       {ECO:0000244|PDB:2C63}.
FT   TURN        213    215       {ECO:0000244|PDB:2C63}.
FT   HELIX       216    234       {ECO:0000244|PDB:2C63}.
SQ   SEQUENCE   246 AA;  28219 MW;  D70FBC100C45D6E5 CRC64;
     MGDREQLLQR ARLAEQAERY DDMASAMKAV TELNEPLSNE DRNLLSVAYK NVVGARRSSW
     RVISSIEQKT MADGNEKKLE KVKAYREKIE KELETVCNDV LSLLDKFLIK NCNDFQYESK
     VFYLKMKGDY YRYLAEVASG EKKNSVVEAS EAAYKEAFEI SKEQMQPTHP IRLGLALNFS
     VFYYEIQNAP EQACLLAKQA FDDAIAELDT LNEDSYKDST LIMQLLRDNL TLWTSDQQDE
     EAGEGN
//